203 related articles for article (PubMed ID: 19911124)
21. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1.
Ito S; Nagaoka H; Shinkura R; Begum N; Muramatsu M; Nakata M; Honjo T
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1975-80. PubMed ID: 14769937
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.
Holden LG; Prochnow C; Chang YP; Bransteitter R; Chelico L; Sen U; Stevens RC; Goodman MF; Chen XS
Nature; 2008 Nov; 456(7218):121-4. PubMed ID: 18849968
[TBL] [Abstract][Full Text] [Related]
23. The inhibition of hepatitis B virus by APOBEC cytidine deaminases.
Janahi EM; McGarvey MJ
J Viral Hepat; 2013 Dec; 20(12):821-8. PubMed ID: 24304451
[TBL] [Abstract][Full Text] [Related]
24. APOBEC: From mutator to editor.
Yang B; Li X; Lei L; Chen J
J Genet Genomics; 2017 Sep; 44(9):423-437. PubMed ID: 28964683
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein B mRNA-editing, catalytic polypeptide cytidine deaminases and retroviral restriction.
Koito A; Ikeda T
Wiley Interdiscip Rev RNA; 2012; 3(4):529-41. PubMed ID: 22549984
[TBL] [Abstract][Full Text] [Related]
26. DNA Editing by APOBECs: A Genomic Preserver and Transformer.
Knisbacher BA; Gerber D; Levanon EY
Trends Genet; 2016 Jan; 32(1):16-28. PubMed ID: 26608778
[TBL] [Abstract][Full Text] [Related]
27. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1.
Xie K; Sowden MP; Dance GS; Torelli AT; Smith HC; Wedekind JE
Proc Natl Acad Sci U S A; 2004 May; 101(21):8114-9. PubMed ID: 15148397
[TBL] [Abstract][Full Text] [Related]
28. The role of cytidine deaminases on innate immune responses against human viral infections.
Vieira VC; Soares MA
Biomed Res Int; 2013; 2013():683095. PubMed ID: 23865062
[TBL] [Abstract][Full Text] [Related]
29. APOBECs and virus restriction.
Harris RS; Dudley JP
Virology; 2015 May; 479-480():131-45. PubMed ID: 25818029
[TBL] [Abstract][Full Text] [Related]
30. Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.
Orecchini E; Frassinelli L; Galardi S; Ciafrè SA; Michienzi A
Chromosome Res; 2018 Mar; 26(1-2):45-59. PubMed ID: 29396793
[TBL] [Abstract][Full Text] [Related]
31. AID/APOBEC-like cytidine deaminases are ancient innate immune mediators in invertebrates.
Liu MC; Liao WY; Buckley KM; Yang SY; Rast JP; Fugmann SD
Nat Commun; 2018 May; 9(1):1948. PubMed ID: 29769532
[TBL] [Abstract][Full Text] [Related]
32. Structural plasticity of substrate selection by activation-induced cytidine deaminase as a regulator of its genome-wide mutagenic activity.
King JJ; Larijani M
FEBS Lett; 2021 Jan; 595(1):3-13. PubMed ID: 33089497
[TBL] [Abstract][Full Text] [Related]
33. Diverse functions for DNA and RNA editing in the immune system.
Hamilton CE; Papavasiliou FN; Rosenberg BR
RNA Biol; 2010; 7(2):220-8. PubMed ID: 20220309
[TBL] [Abstract][Full Text] [Related]
34. Biochemical basis of immunological and retroviral responses to DNA-targeted cytosine deamination by activation-induced cytidine deaminase and APOBEC3G.
Chelico L; Pham P; Petruska J; Goodman MF
J Biol Chem; 2009 Oct; 284(41):27761-27765. PubMed ID: 19684020
[TBL] [Abstract][Full Text] [Related]
35. APOBEC-1 and AID are nucleo-cytoplasmic trafficking proteins but APOBEC3G cannot traffic.
Bennett RP; Diner E; Sowden MP; Lees JA; Wedekind JE; Smith HC
Biochem Biophys Res Commun; 2006 Nov; 350(1):214-9. PubMed ID: 16999936
[TBL] [Abstract][Full Text] [Related]
36. Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase.
Nowarski R; Britan-Rosich E; Shiloach T; Kotler M
Nat Struct Mol Biol; 2008 Oct; 15(10):1059-66. PubMed ID: 18820687
[TBL] [Abstract][Full Text] [Related]
37. Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases.
Siriwardena SU; Chen K; Bhagwat AS
Chem Rev; 2016 Oct; 116(20):12688-12710. PubMed ID: 27585283
[TBL] [Abstract][Full Text] [Related]
38. Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus.
Peng ZG; Zhao ZY; Li YP; Wang YP; Hao LH; Fan B; Li YH; Wang YM; Shan YQ; Han YX; Zhu YP; Li JR; You XF; Li ZR; Jiang JD
Hepatology; 2011 Apr; 53(4):1080-9. PubMed ID: 21480314
[TBL] [Abstract][Full Text] [Related]
39. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation.
Durandy A
Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279
[TBL] [Abstract][Full Text] [Related]
40. NMR assignments and the identification of the secondary structure of the anti-retroviral cytidine deaminase.
Furukawa A; Nagata T; Habu Y; Sugiyama R; Hayashi F; Yokoyama S; Takaku H; Katahira M
Nucleic Acids Symp Ser (Oxf); 2008; (52):183-4. PubMed ID: 18776314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]